Lizama BN, Williams C, North HA, Pandey K, et al. CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease. Alzheimers Dement 2024 Aug 21. doi: 10.1002/alz.14152.
PMID: 39166791